Region: 

Blog posts tagged with 2bPrecise

  • 4 common objections to genomic medicine 2

    Joel Diamond, MD
    November 07, 2017

    Genomic medicine has its skeptics. Unfortunately, many doubts are based on misconceptions about the field. Here are some of the objections I have heard recently, along with evidence to overcome them. Read more…

  • Hype or science? Genetic testing in sports

    Joel Diamond MD
    October 12, 2017

    Personal genetic testing is increasingly popular, but it’s a mixture of real science and marketing hype. One area is especially prone to exaggerated promise and possibility: Sports. Read more…

  • Epigenetics: How environment can alter genes for generations 1

    Joel Diamond MD
    September 27, 2017

    There is a growing body of work in a field known as epigenetics, the study of inherited changes to gene expression, while the underlying DNA sequence remains unchanged. It means that individual lifestyle and environment can “turn on” or “turn off” genes in later years, or even in later generations. Read more…

  • Turning genomic challenges into opportunities 2

    Joel Diamond MD
    May 24, 2017

    While knowledge and technology around genomics has progressed at a rate previously unseen in science, many of the original challenges and opportunities still exist today. Read more…

  • Consumers have a growing appetite for genomic medicine

    Joel Diamond MD
    March 29, 2017

    In my practice, I have seen a sharp rise in the number of patients asking about genetic and genomic tests. Healthcare consumers are drawn to the idea that this information can unlock answers to persistent health problems, or reveal risk for future issues. And a proliferation of accessible, affordable testing has whet their appetite for much more. Read more…

  • Why behavioral health experts are turning to precision medicine

    Joel Diamond MD
    March 02, 2017

    As physicians, we want to offer the best possible care plan for every patient, every time. We want tools that help us incorporate the many factors that affect each individual. This is where precision medicine comes in. Oncology is one discipline that is already using genomics extensively, and there is now a burgeoning use in other areas, including a significant interest in pharmacogenomics to improve care for behavioral health patients. Read more…

  • Top 3 headlines from HIMSS 2017

    Ann Marie Beasley
    February 28, 2017

    HIMSS 2017, the largest industry event in the U.S., drew more than 42,000 healthcare IT professionals to Orlando, Florida, last week. After hundreds of conversations with clients, partners and colleagues, we’re even more energized to achieve our vision of building open, connected communities of health. Of the many phenomenal insights and events during the week, there are three major highlights that bear repeating. Read more…

  • The precision medicine learning curve

    Joel Diamond MD
    February 20, 2017

    The concept of applying genomics and precision medicine is gaining momentum. Physicians are enthusiastic about the potential of personalized care plans to improve patient outcomes. But several questions remain for physicians who must put precision medicine into practice, including these. Read more…

  • Briefing Congress on health IT innovation

    Paul Black
    September 16, 2016

    This week I testified before the United States House of Representatives. It was an honor to represent the healthcare IT industry and share how innovations are driving efficiencies and improvements. Here are excerpts from that testimony: Despite some bumps in the road, as can be expected in times of change, there have been huge leaps forward in our industry in recent years that never would have happened had Congress not provided the impetus for ubiquitous adoption of electronic health records (EHRs). Read more…

  1. 1

About This Blog

It Takes a Community is a place for stories about building open, connected communities of health. Together we can enable smarter care, delivered with greater precision, for healthier patients, populations and communities. Join the conversation with comments and stories of your own.

Subscribe

Archive

What can we do for you?